MEDIDATA AI-ENHANCED SOLUTION TO FAST-TRACK EISAI’S DATA REVIEW, RECONCILIATION BY 80 PCT
KUALA LUMPUR, Medidata has been selected by Eisai Inc (Eisai), the United States (US) pharmaceutical subsidiary of Tokyo-based Eisai Co Ltd, as one of the first customers to harness its recently announced artificial intelligence (AI)-driven Medidata Clinical Data Studio. Eisai will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and complex clinical trials, and enhance patient experience, according to Medidata in a statement. ‘Through Clinical Data Studio, Eisai is enabling healthcare stakeholders to overcome the complexities of modern clinical trials and foster collaboration on cleaner, more actionable data. ‘By delivering